
Loading, please wait...

Loading, please wait...

Clinicians increasingly adopt self-administered capillary blood collection devices for both remote patient care and clinical research. While the Tasso+ system usually provides a safe and user-friendly experience, practitioners must remain vigilant regarding potential capillary blood collection complications. A recent case report highlights an unexpected adverse effect that led to surgical intervention and permanent scarring. Consequently, this incident underscores the necessity of understanding how device design interacts with individual skin anatomy.
In this specific case, a female study participant used a CE-certified Tasso+ device to collect 500 µL of whole blood. Initially, the collection process proceeded without any immediate issues or pain. However, the participant later developed a significant gaping lesion at the application site. Therefore, she required formal surgical treatment to close the wound. Despite successful surgery, the incident left a small, permanent scar on her skin. Moreover, this represents a previously undocumented complication for this specific device model, suggesting that safety profiles for self-sampling tools require continuous monitoring.
The researchers involved in the case study believe the primary cause relates to the interaction between the device's puncture mechanism and the patient’s skin tension lines. Furthermore, when a puncture occurs perpendicular to these tension lines, the risk of the wound opening or “gaping” increases significantly. Additionally, the study suggests that device placement instructions must account for these biomechanical factors to prevent similar capillary blood collection complications. Specifically, future iterations of self-administered systems should perhaps incorporate orientation guides to align punctures with natural skin folds. Ultimately, while self-sampling technology offers great promise for Indian healthcare and remote monitoring, safety evaluations must remain a top priority for manufacturers and clinicians alike.
Yes, the Tasso+ is a CE-certified device and is generally regarded as safe and efficient for collecting small volumes of whole blood. However, like any medical device, rare complications such as scarring can occur.
Skin tension lines, or Langer's lines, dictate how the skin naturally pulls. If a device punctures the skin across these lines, the wound is more likely to gape open, which can lead to scarring or the need for surgical closure.
Patients should immediately contact their healthcare provider. If a wound does not close or looks deeper than a standard needle prick, it may require professional medical assessment or even minor surgical intervention.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Müller F et al. Unexpected scarring following use of capillary self-blood collection device: A case report and discussion of device design. J Vasc Access. 2026 Feb 06. doi: 10.1177/11297298251415110. PMID: 41645967.
Dasari H et al. Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials. PLOS ONE. 2024 May 29. doi: 10.1371/journal.pone.0304155.
World Health Organization. WHO guidelines on drawing blood: best practices in phlebotomy. Geneva: World Health Organization; 2010.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A case report discusses a permanent scar following use of the Tasso+ device, prompting a re-evaluation of skin tension and device safety....
8 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today